Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Common Synapse has just published The Unprompted Patient Journey – Patient Intelligence Report 2026, bringing together 3,835 public patient, caregiver and clinician narratives from six studies across eight neuro-related conditions.
Read the report here:
https://commonsynapse.com/case-studies/CommonSynapse_The_Unprompted_Patient_Journey_2026.pdf
We are seeking a Discovery DMPK Scientist (Senior Scientist II / Principal Scientist depending on experience). You will be part of a dynamic and innovative environment and will become an integral part of our vision to address patients’ unmet needs while building Britain’s Biggest Biotech. You will use your DMPK expertise and scientific curiosity to solve drug discovery challenges, as part of multi-disciplinary project teams. You will be able to work in state-of-the-art laboratory and modern facilities for optimum collaboration alongside a focused and caring team.
Life science has become a networked industry. As companies grow, capital often scales faster than internal teams, while the capability that matters most – from commercial expertise and manufacturing to regulatory knowledge and international access - increasingly sits with partners rather than on the payroll.
So what does that mean for leadership?
The successful candidate will join the Kornfeld group to investigate how learned behaviours are encoded in the brain’s synaptic networks. The role will involve conducting high-resolution 3D electron microscopy and expansion microscopy experiments to map the synaptic connections in various model organisms. You will be responsible for tissue preparation, imaging, and data acquisition, followed by the detailed analysis of these vast datasets.
We're looking for a Scientific Editor to join our Data and Community Function, helping to curate, enhance, and promote the world-renowned Cambridge Structural Database (CSD), a critical resource used by scientists across academia and industry worldwide.
This is a unique opportunity to play a key role in maintaining the quality and integrity of structural chemistry data while contributing to scientific training, outreach, and education initiatives that support the global research community.
About the Role
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle® molecules attractive candidates for drug development.
How are organizations architecting functional Artificial Intelligence (AI) strategies that will shape the next phase of AI in Medical Affairs?
Earlier this year, Digital Science brought together Medical Affairs leaders to explore how they’re approaching AI, and why they need to embed sustainable AI capabilities in day-to-day workflows.
The conversation covered six key topics: